tradingkey.logo

Park Ha Biological Technology Co Ltd

PHH

0.516USD

-0.047-8.36%
Cierre 08/28, 16:00ETCotizaciones retrasadas 15 min
12.90MCap. mercado
--P/E TTM

Park Ha Biological Technology Co Ltd

0.516

-0.047-8.36%
Más Datos de Park Ha Biological Technology Co Ltd Compañía
Park Ha Biological Technology Co Ltd is an investment holding company primarily engaged in developing private skincare label, direct skincare products sales and franchise alliances promotions. The Company mainly operates its business through two segments. The Products Sales segment is engaged in providing skincare and cosmetic products under the brand name Park Ha as well as offering complimentary after-sales beauty services in physical stores. The Franchise Service segment is engaged in entering franchise agreements with its franchisees, pursuant to which the franchisees are granted permission to open and operate a store under the brand name Park Ha or Geni. The Company's products include Little Blue Injection Serum, Parkha Amino Acid Cleansing Foam and other products. The Company mainly conducts its business in domestic market.
Información de la empresa
Símbolo de cotizaciónPHH
Nombre de la empresaPark Ha Biological Technology Co Ltd
Fecha de salida a bolsaDec 27, 2024
Director ejecutivoMs. Xiaoqiu Zhang
Número de empleados31
Tipo de seguridadOrdinary Share
Fin del año fiscalDec 27
Dirección14F, Building 3
CiudadWUXI
Bolsa de valoresNASDAQ Capital Market Consolidated
PaísChina
Código postal214135
Teléfono864000127562
Sitio Webhttp://ir.parkha.cn/
Símbolo de cotizaciónPHH
Fecha de salida a bolsaDec 27, 2024
Director ejecutivoMs. Xiaoqiu Zhang
Ejecutivos de la empresa
Nombre
Nombre/Posición
Posición
Accionistas
Cambio
Ms. Xiaoqiu Zhang
Ms. Xiaoqiu Zhang
Chairman of the Board, Chief Executive Officer
Chairman of the Board, Chief Executive Officer
--
--
Ms. Xiaoyan Zhu
Ms. Xiaoyan Zhu
Chief Financial Officer
Chief Financial Officer
--
--
Ms. Xinyu Li
Ms. Xinyu Li
Chief Technology Officer, Product Manager
Chief Technology Officer, Product Manager
--
--
Ms. Li Wang
Ms. Li Wang
Director
Director
--
--
Ms. Yanan Shan
Ms. Yanan Shan
Independent Director Nominee
Independent Director Nominee
--
--
Mr. Qixiong Sheng
Mr. Qixiong Sheng
Independent Director
Independent Director
--
--
Mr. Xiaozhong Yu
Mr. Xiaozhong Yu
Independent Director Nominee
Independent Director Nominee
--
--
Nombre
Nombre/Posición
Posición
Accionistas
Cambio
Ms. Xiaoqiu Zhang
Ms. Xiaoqiu Zhang
Chairman of the Board, Chief Executive Officer
Chairman of the Board, Chief Executive Officer
--
--
Ms. Xiaoyan Zhu
Ms. Xiaoyan Zhu
Chief Financial Officer
Chief Financial Officer
--
--
Ms. Xinyu Li
Ms. Xinyu Li
Chief Technology Officer, Product Manager
Chief Technology Officer, Product Manager
--
--
Ms. Li Wang
Ms. Li Wang
Director
Director
--
--
Ms. Yanan Shan
Ms. Yanan Shan
Independent Director Nominee
Independent Director Nominee
--
--
Mr. Qixiong Sheng
Mr. Qixiong Sheng
Independent Director
Independent Director
--
--
Desglose de ingresos
FY2024
FY2023
FY2022
FY2021
Sin datos
Por regiónCNY
Nombre
Ganancia
Proporción
China (Mainland)
2.38M
0.00%
Por negocio
Por región
Sin datos
Estadísticas de accionistas
Actualizado: sáb., 23 de ago
Actualizado: sáb., 23 de ago
Accionistas
Tipos de accionistas
Accionistas
Accionistas
Proporción
Xiaoqiu Holding Ltd
64.85%
Changxin International Ltd Partnership
8.51%
Citadel Advisors LLC
0.07%
Invesco Capital Management LLC
0.07%
Geode Capital Management, L.L.C.
0.06%
Otro
26.44%
Accionistas
Accionistas
Proporción
Xiaoqiu Holding Ltd
64.85%
Changxin International Ltd Partnership
8.51%
Citadel Advisors LLC
0.07%
Invesco Capital Management LLC
0.07%
Geode Capital Management, L.L.C.
0.06%
Otro
26.44%
Tipos de accionistas
Accionistas
Proporción
Corporation
81.71%
Investment Advisor
0.16%
Research Firm
0.13%
Hedge Fund
0.08%
Investment Advisor/Hedge Fund
0.06%
Otro
17.86%
Participación institucional
Actualizado: mar., 1 de jul
Actualizado: mar., 1 de jul
Periodo del informe
Número de instituciones
Acciones mantenidas
Proporción
Cambio
2025Q2
9
21.62M
81.98%
-25.58K
2025Q1
8
21.60M
81.90%
-29.47K
2024Q4
6
21.63M
82.55%
+21.63M
Actividad de los accionistas
Nombre
Acciones mantenidas
Proporción
Cambio
Cambio %
Fecha
Xiaoqiu Holding Ltd
19.05M
72.23%
--
--
Feb 24, 2025
Changxin International Ltd Partnership
2.50M
9.48%
--
--
Feb 24, 2025
Citadel Advisors LLC
16.61K
0.06%
-13.13K
-44.16%
Mar 31, 2025
Geode Capital Management, L.L.C.
16.79K
0.06%
+16.79K
--
Mar 31, 2025
Ver más
ETFs relacionados
Actualizado: mié., 6 de ago
Actualizado: mié., 6 de ago
Nombre
Proporción
Invesco Golden Dragon China ETF
0.01%
Invesco Golden Dragon China ETF
Proporción0.01%
Dividendos
Un total de 0.00 USD se ha distribuido en dividendos durante los últimos 5 años.
Fecha
Dividendos
Fecha de registro
Fecha de pago
Fecha ex-dividendo
Sin datos
División de acciones
Fecha
Tipo
Relación
Sin datos
Fecha
Tipo
Relación
Sin datos
KeyAI